Neeraj Agarwal outlines the findings of the metastatic castration-resistant prostate cancer cohort of the COSMIC-021 trial of cabozantinib plus atezolizumab presented as a poster at ASCO GU 2020 (3:21).
17-02-2020 | ASCO GU 2020 | Conference coverage | Video